Llaneras, Jordi <br/><br/>
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs.  [electronic resource] 

 -  Journal of hepatology  10 2019 
 - 666-672 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1600-0641 
<br/><br/><label>Standard No.: </label>10.1016/j.jhep.2019.06.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aminoisobutyric Acids<br/>Antiviral Agents--administration & dosage<br/>Carbamates--administration & dosage<br/>Cyclopropanes<br/>Drug Combinations<br/>Drug Monitoring--methods<br/>Drug Resistance, Viral<br/>Female<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Heterocyclic Compounds, 4 or More Rings--administration & dosage<br/>Humans<br/>Lactams, Macrocyclic<br/>Leucine--analogs & derivatives<br/>Liver Cirrhosis--diagnosis<br/>Macrocyclic Compounds--administration & dosage<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Quinoxalines<br/>Sofosbuvir--administration & dosage<br/>Spain--epidemiology<br/>Sulfonamides--administration & dosage<br/>Sustained Virologic Response<br/>Treatment Outcome